2023
DOI: 10.1002/mco2.237
|View full text |Cite|
|
Sign up to set email alerts
|

Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA

Abstract: Cisplatin (DDP) is a common therapeutic option for non‐small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. Therefore, identifying novel biomarkers to improve the diagnosis and treatment of NSCLC is important. Ubiquitin‐specific protease (USP14) is involved in various pathological conditions including cancer; however, the role of USP14 in NSCLC remains elusive. The SELEX technology was used to identify aptamers that specifically recognize DDP‐resistant lung cancer … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 57 publications
0
2
0
Order By: Relevance
“…[113][114][115] Moreover, it explores the exciting prospects of synergistic inter-actions when these nanoparticles are combined with cisplatin, a prominent chemotherapy agent. [116,117] The mean publication years for these terms, spanning from 2020.2 to 2020.3, emphasize the currency of these explorations.…”
Section: Contemporary Topics Per Clustermentioning
confidence: 99%
“…[113][114][115] Moreover, it explores the exciting prospects of synergistic inter-actions when these nanoparticles are combined with cisplatin, a prominent chemotherapy agent. [116,117] The mean publication years for these terms, spanning from 2020.2 to 2020.3, emphasize the currency of these explorations.…”
Section: Contemporary Topics Per Clustermentioning
confidence: 99%
“…In the process of checking the raw data, 1 we noted that the images of A549 group in Figure 4F were misplaced by mistake. The corrected Figure 4F should be as shown below.…”
mentioning
confidence: 99%